Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $65.07 USD
Change Today +1.57 / 2.47%
Volume 1.6M
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Antoni Ribas M.D., Ph.D.

Member of Scientific Advisory Board, Kite Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background*

Dr. Antoni Ribas, M.D., PhD serves as an Associate Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center, Director of the Cell and Gene Therapy Core Facility, and training faculty at the Broad Stem Cell Research Center at UCLA. Dr. Ribas serves as Professor of Medicine, Hematology/Oncology, Surgical Oncology and Director of the Cell and Gene Therapy Core Facility at the University of California, Los Angeles. Dr. Ribas served as Senior Vice ...

Read Full Background

Corporate Headquarters*

2225 Colorado Avenue
Santa Monica, California 90404

United States

Phone: 310-824-9999
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Post-Doctoral Training
University of California-Los Angeles
Unknown/Other Education
Universitat de Barcelona

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KITE:US $65.07 USD +1.57

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KITE PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.